BD expands integrated medication management to help tackle hospital drug diversion

BD (Becton, Dickinson, and Company) has launched a new software application designed to help hospitals and health systems identify drug diversion at the 2018 American Society of Health-System Pharmacists (ASHP) midyear meeting. As part of the BD HealthSight platform that is designed to support enterprise-wide medication management, the new BD HealthSight diversion management application is the next step in the company’s efforts to address drug diversion through integrated solutions and analytics. The solution leverages data from existing BD products, including the BD Pyxis ES system, and the electronic medical record to provide actionable insights to assist with a hospital or health system’s diversion investigations.

The new BD HealthSight diversion management application is designed to address the unique challenges associated with diversion by tracking patterns and risky behavior to help identify diverters as early as possible. BD has partnered with Microsoft, who brings industry leading expertise in artificial intelligence (AI) and data science methodologies, to support development of these machine-learning based algorithms. Importantly, the application also aggregates EMR and dispensing cabinet data to automate a normally time-consuming and tedious manual review process to reconcile and automatically flag anomalous dispense, administration, and waste transactions.